SAS Offers for Commercial Sphere

Medical Sciences
Technology for determination of dosing schedules for substances with narrow therapeutic windows and/or very expensive drugs.
PC-controlled infusion dosing of factor VIII to hemophilic patients.
Markers detection on neoplastic blood cells (phenotyping of leukemia lymphoma cells) which makes the diagnosis more exact and the selection of chemotherapeutic treatment in individual patients on the basis of detected markers.
Familial Adenomatous Polyposis of Colon (FAP)
Molecular-genetic approaches to the testing of hereditary predisposition to non-polyposis colorectal cancer (Hereditary Non-Polyposis Colorectal Cancer – HNPCC)
Hereditary predisposition to the breast and ovary cancers (BRCA1 and BRCA2 genes)
Molecular-genetic testing of hereditary predisposition to multiple endocrine neoplasia type 2A (MEN2A)
Detection of mutagenicity and carcinogenicity of chemical compounds
Flow cytometric functional analysis of multidrug phenotype of malignant hematopoetic cells
The investigation of bone marrow parablasts in leukemic patients with cytostatics chosen.
Toxicity Studies - Acute, Subchronic & Chronic
Diagnosis of Q fever and other rickettsial infection
Diagnosis of chlamydial infections
Vectorcardigraphic examinations
The examinations of oculomotor regulations.
Stabilometric examination
The set of mouse-hybridomas producing monoclonal antibodies against tau proteint, beta amyloid protein and tyrosine kinase receptors.
Antigens for diagnostics of Q fever and other rickettsial infections
Antigens for diagnostics of chlamydial infections